Mark Slaughter

Summary

Publications

  1. ncbi request reprint Embol-X intra-aortic filtration system: capturing particulate emboli in the cardiac surgery patient
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    J Extra Corpor Technol 37:222-6. 2005
  2. ncbi request reprint A new method of monitoring recovery and weaning the Thoratec left ventricular assist device
    M S Slaughter
    Division of Cardiothoracic Surgery, Christ Hospital and Medical Center, Oak Lawn, Illinois, USA
    Ann Thorac Surg 71:215-8. 2001
  3. ncbi request reprint Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 52:228-33. 2006
  4. ncbi request reprint Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device
    Mark S Slaughter
    Advocate Christ Medical Center, Oak Lawn, Ill 60453, USA
    J Thorac Cardiovasc Surg 133:1573-80. 2007
  5. ncbi request reprint Destination therapy: the future is arriving
    Mark S Slaughter
    Department of Cardiothoracic Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:155-6. 2005
  6. ncbi request reprint Utilization of acoustic signatures to identify HeartMate XVE device end-of-life
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 26:579-83. 2007
  7. ncbi request reprint Managing mechanical valves with reduced anticoagulation
    Mark S Slaughter
    Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA
    Expert Rev Cardiovasc Ther 5:1073-85. 2007
  8. pmc Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device
    Mark S Slaughter
    Cardiac Surgery Research and Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    Tex Heart Inst J 35:245-9. 2008
  9. ncbi request reprint Myocardial recovery after chronic mechanical assist device support: fact or fiction?
    Mark Slaughter
    Mechanical Assist Device Program, Department of Cardiothoracic Surgery, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL 60453, USA
    Congest Heart Fail 10:74-5. 2004
  10. pmc HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Tex Heart Inst J 36:12-6. 2009

Collaborators

Detail Information

Publications33

  1. ncbi request reprint Embol-X intra-aortic filtration system: capturing particulate emboli in the cardiac surgery patient
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    J Extra Corpor Technol 37:222-6. 2005
    ..Clearly, the reduction of particulate matter by as much as 95% justifies its use in cardiac surgery patients identified with an increased pre-operative embolic risk...
  2. ncbi request reprint A new method of monitoring recovery and weaning the Thoratec left ventricular assist device
    M S Slaughter
    Division of Cardiothoracic Surgery, Christ Hospital and Medical Center, Oak Lawn, Illinois, USA
    Ann Thorac Surg 71:215-8. 2001
    ..Evaluating and monitoring patients for myocardial recovery and the optimal methods of weaning the left ventricular assist device are not well defined...
  3. ncbi request reprint Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 52:228-33. 2006
    ..The long-term effects of steady-state and transient LV mechanical reloading on myocardial structure and function toward achieving sustained myocardial recovery warrant further investigation...
  4. ncbi request reprint Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device
    Mark S Slaughter
    Advocate Christ Medical Center, Oak Lawn, Ill 60453, USA
    J Thorac Cardiovasc Surg 133:1573-80. 2007
    ..3 m(2). Results of the multicenter clinical trial are reviewed...
  5. ncbi request reprint Destination therapy: the future is arriving
    Mark S Slaughter
    Department of Cardiothoracic Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:155-6. 2005
  6. ncbi request reprint Utilization of acoustic signatures to identify HeartMate XVE device end-of-life
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 26:579-83. 2007
    ..In this study we assess a non-invasive technique using acoustic signals generated from the HeartMate XVE LVAD to potentially identify impending device end-of-life issues...
  7. ncbi request reprint Managing mechanical valves with reduced anticoagulation
    Mark S Slaughter
    Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA
    Expert Rev Cardiovasc Ther 5:1073-85. 2007
    ..The current trend is more frequent use of bioprosthetic valves; however, this trend may again reverse as therapy for mechanical valves is refined...
  8. pmc Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device
    Mark S Slaughter
    Cardiac Surgery Research and Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    Tex Heart Inst J 35:245-9. 2008
    ..They also suggest that modifications made to the HeartMate LVAD since the REMATCH trial have resulted in fewer complications, and that better patient selection and supportive care have improved outcomes...
  9. ncbi request reprint Myocardial recovery after chronic mechanical assist device support: fact or fiction?
    Mark Slaughter
    Mechanical Assist Device Program, Department of Cardiothoracic Surgery, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL 60453, USA
    Congest Heart Fail 10:74-5. 2004
  10. pmc HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Tex Heart Inst J 36:12-6. 2009
    ..Further in vivo testing is planned. Herein, we discuss the unique design of the HeartWare miniature ventricular assist device, our feasibility study of its performance, and the possibilities for its use in human beings...
  11. ncbi request reprint Current and potential applications of left ventricular assist devices
    Pamela Cianci
    Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    J Cardiovasc Nurs 18:17-22. 2003
    ..As VAD science advances, nurses will needs to understand its practice implications...
  12. ncbi request reprint Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Perfusion 20:31-7. 2005
    ..Evaluate the feasibility and clinical significance of crystalloid prime reduction during the initiation of cardiopulmonary bypass (CPB) using a modified bridge on the cardioplegia delivery system...
  13. doi request reprint Reducing emboli in cardiac surgery: does it make a difference?
    Mark S Slaughter
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Artif Organs 32:880-4. 2008
    ....
  14. doi request reprint Intraoperative evaluation of the HeartMate II flow estimator
    Mark S Slaughter
    Division of Cardiothoracic Surgery, Cardiovascular Innovation Institute, University of Louisville, Kentucky, USA
    J Heart Lung Transplant 28:39-43. 2009
    ..This study evaluated the accuracy of HeartMate II flow estimation at the time of implantation...
  15. doi request reprint Advanced heart failure treated with continuous-flow left ventricular assist device
    Mark S Slaughter
    Advocate Christ Medical Center, Oak Lawn, IL, USA
    N Engl J Med 361:2241-51. 2009
    ..New continuous-flow devices are smaller and may be more durable than the pulsatile-flow devices...
  16. ncbi request reprint Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement
    Chad M Feldman
    Advocate Christ Medical Center, Mechanical Assist Device Program, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 25:1410-2. 2006
    ..We report on two patients with bioprosthetic aortic valve replacement for aortic insufficiency at the time of HeartMate II LVAD insertion...
  17. ncbi request reprint Peripheral cardiopulmonary bypass with modified assisted venous drainage and transthoracic aortic crossclamp: optimal management for robotic mitral valve repair
    Michael A Sobieski
    Division of Cardiac Surgery, Christ Hospital and Medical Center, Oak Lawn, IL, USA
    Perfusion 18:307-11. 2003
    ..This approach may be applied to other forms of minimally invasive cardiac surgery that requires CPB...
  18. ncbi request reprint Percutaneous endoscopic gastrostomy tube in a patient with a left ventricular assist device
    Mark S Slaughter
    Division Cardiac Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 W 95th Street, Suite 205, Oak Lawn, IL 60453, USA
    ASAIO J 49:611-2. 2003
    ..We believe that PEG placement should be cpnsidered in patients with an LVAD with swallowing difficulties or who are debilitated are not meeting their caloric requirements...
  19. ncbi request reprint Home discharge experience with the Thoratec TLC-II portable driver
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 53:132-5. 2007
    ..There were no readmissions for device malfunction, emergency battery utilization or back-up unit use. These results demonstrate that the Thoratec TLC-II portable driver is safe, reliable, and can be effectively managed at home...
  20. doi request reprint Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device
    Mark S Slaughter
    Cardiac Surgery Research, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    ASAIO J 54:115-9. 2008
    ..Three nonfatal bleeding events but no thromboembolic events were observed. Fibrinolytic responses initially increase after LVAD implantation but then gradually normalize...
  21. doi request reprint Destination therapy: one-year outcomes in patients with a body mass index greater than 30
    Laura A Coyle
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Artif Organs 34:93-7. 2010
    ..2 vs. 1.6), and survival (63% vs. 65%). Our initial results demonstrate that morbidly obese patients with end-stage heart failure with a contraindication for transplant may successfully undergo implantation of an LVAD for DT...
  22. doi request reprint Improvement in early oxygen uptake kinetics with left ventricular assist device support
    Chad M Feldman
    Internal Medicine, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:406-11. 2008
    ..7 seconds to 35.8 +/- 13.3 seconds (p = 0.046) with LVAD support. Improved oxygen kinetics suggests improved peripheral utilization of oxygen, and may offer an additional clinical parameter to predict the likelihood of sustained recovery...
  23. ncbi request reprint The Thoratec mobile computer: initial in-hospital and outpatient experience
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 50:373-5. 2004
    ..Data were successfully obtained in all cases. Documentation of programmed settings and driver operation was achieved without difficulty...
  24. ncbi request reprint Minimally invasive mitral valve repair using the da Vinci robotic system
    Antone J Tatooles
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    Ann Thorac Surg 77:1978-82; discussion 1982-4. 2004
    ..We evaluated our da Vinci robotically assisted mitral valve repair experience toward achieving this goal...
  25. doi request reprint Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome?
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:203-6. 2008
    ..Despite the significant reductions in IL-6 and PNE, there was no effect on clinical outcomes. Additional studies are needed to demonstrate a clinically significant effect on patient outcomes...
  26. doi request reprint Destination therapy: safety and feasibility of national and international travel
    Laura A Coyle
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:172-6. 2008
    ..All patients returned home safely for routine follow-up. Long-distance travel is possible for DT patients. Anticipating potential problems and careful planning is necessary for safe national and international travel...
  27. ncbi request reprint Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, USA
    Circulation 116:497-505. 2007
    ..In the present study, we describe outcomes of DT in the post-REMATCH era in the United States...
  28. ncbi request reprint Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study
    James W Long
    Utah Artificial Heart Program, LDS Hospital, 8th Avenue and C Street, Salt Lake City, UT 84143, USA
    Congest Heart Fail 11:133-8. 2005
    ..Given that these DT patients were similar to those in the REMATCH trial, the improved outcomes likely reflect improvements in the HeartMate XVE LVAD and experience with patient management...
  29. ncbi request reprint North American multicenter experience with the On-X prosthetic heart valve
    Kathleen W McNicholas
    Christiana Care Health System, Newark, DE, USA
    J Heart Valve Dis 15:73-8; discussion 79. 2006
    ..This ongoing, longitudinal, multi-center, North American study was designed to evaluate the safety and effectiveness of the On-X valve...
  30. ncbi request reprint Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device
    Adam R Travis
    Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA
    J Thorac Cardiovasc Surg 133:517-24. 2007
    ....
  31. ncbi request reprint In vivo evaluation of the biocompatibility of the totally implantable ventricular assist device (HeartSaver VAD)
    Tofy Mussivand
    University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    ASAIO J 49:459-62. 2003
    ..7 +/- 42.6 mg/dl. Several device related improvements were identified and have now been implemented. Additional bovine implants with an optimized device are currently underway in preparation for human trials...
  32. ncbi request reprint Emboli capture using the Embol-X intraaortic filter in cardiac surgery: a multicentered randomized trial of 1,289 patients
    Michael K Banbury
    The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 76:508-15; discussion 515. 2003
    ..Particulate emboli are thought to play a significant role in the development of cardiac surgical complications. Intraaortic filtration of particulate emboli may reduce the burden of this morbidity in cardiac patients...
  33. ncbi request reprint Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era
    Leslie W Miller
    Cardiovascular Division, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Heart Lung Transplant 25:778-84. 2006
    ..Prior studies have examined hospital costs for LVAD implants performed during investigational studies (e.g., REMATCH), but none has been published since that trial was completed...